MT-ATP6 pseudogene 10 (MTATP6P10)

MT-ATP6 pseudogene 10 is classified as a pseudogene that shows sequence similarity to the functional MT-ATP6 gene, which encodes a subunit of the mitochondrial ATP synthase complex vital for oxidative phosphorylation and ATP production[1][2][4]. However, pseudogenes like MTATP6P10 do not code for functional proteins and there is no evidence that MTATP6P10 performs any biological or pharmacological role. The functional relevance and disease association applies to MT-ATP6, not to its pseudogenes (numbered like "pseudogene 10")[1][2][4]. Therefore, MTATP6P10 is not considered a therapeutic or diagnostic target, nor does it have any associated mechanisms of drug action, biomarker relevance, or safety concerns. Key notes: - MT-ATP6 (not the pseudogene) is an established therapeutic target involved in mitochondrial disorders such as Leigh syndrome, NARP syndrome, and others[1][2][4][5][6]. - MTATP6P10 (the pseudogene discussed here) does not encode a protein, is not a therapeutic target, and has no established function or disease association in the current literature.

Other names

mitochondrially encoded ATP synthase 6 pseudogene 10MTATP6P10